July 9th 2025
Daniel Jernazian, a two-time cancer survivor, shares how sports, advocacy and meeting his idol shaped his journey through illness and recovery.
July 2nd 2025
In part 4, the author reflects on her mother’s silent strength and unwavering love during her cancer journey, as she cared for her daughter while silently battling her own illness.
July 1st 2025
Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect quality of life over time.
June 28th 2025
At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope.
June 27th 2025
CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, says Dr. André Goy.
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia
An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.
In a World of Rushing, Cancer Taught Me to Slow Down
With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.
Patients With Lower-Risk Myelofibrosis May Respond to Jakafi
Although Jakafi has been approved for patients with higher-risk myelofibrosis, those with lower-risk disease may also benefit from this treatment.
Why Transfusion Independence Matters for Patients With MDS
An expert explained the burden that red blood cell transfusions can place on patients with MDS.
My Worries About Being Old as an MDS Survivor
Having myelodysplastic syndromes has taught me to cherish every day and to pursue the things that matter to me, like publishing a book I’ve been writing.
‘Tempo’ of MDS Helps With Timing for Stem Cell Transplants
For patients with MDS, close monitoring by doctors may help determine the appropriate timing to undergo stem cell transplants before the disease worsens.
Essential Thrombocythemia Trial Launched Evaluating Bomedemstat
The Shorespan-007 trial will investigate the new drug among patients with essential thrombocythemia who have not previously received cytoreductive therapy.
How Bispecific Antibodies Work and What Patients Can Expect
Bispecific antibodies connect the immune system with cancer cells. They offer an efficacious treatment option, but there are side effects.
6 FDA Cancer Approvals from August 2024
In August 2024, the FDA approved six new cancer treatments, including some that haven’t previously been approved.
Cancer Survivors and Olympians Need to Be in Tune With Their Bodies
Just like athletes in the Olympics, it's important for cancer survivors to keep track of everything they feel and to know their bodies well.
NCCN Recommends Rytelo for Anemia in Patients With MDS
The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions.
After CAR-T Cell Therapy, Monitor for These Symptoms at Home
Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.
Iopofosine I 131 Is Promising Across Waldenstrom’s Macroglobulinemia Types
Eighty percent of patients with relapsed or refractory Waldenstrom’s macroglobulinemia responded to treatment with iopofosine I 131, researchers found.
5 Factors Linked to Greater Chance of Polycythemia Vera Progression
Researchers identified five traits that may increase a person’s chance of experiencing polycythemia vera progression.
Iclusig Leads to Better Responses Than Gleevec in Leukemia Subset
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia had better MRD statuses after receiving Iclusig, compared with Gleevec.
Survivors May Have Successful Pregnancies After Stem Cell Transplants
Contrary to past research, blood cancer survivors may have safe and successful pregnancies up to 10 years after an allogeneic stem cell transplant.
My Invisible Losses That Emerge from Cancer
Although MDS didn’t leave physical scars, the invisible ones, like side effects from treatment, are ones that linger.
Antibody Testing May Decrease Infection Risk in Blood Cancer Survivors
More frequent immunoglobulin G testing was associated with a decreased risk of severe infections in patients with CLL and non-Hodgkin lymphoma.
Some With MDS May Benefit from Delaying Stem Cell Transplants
For patients with MDS who benefit from delaying transplants, it’s important to take care of their health while savoring their time before transplant.
Don Omar Announces Being Cancer Free, ‘General Hospital’ Star Opens Up About Cancer and More
From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.
My Feeling of Survivor’s Guilt
As a cancer survivor, I realize that life doesn’t always go the way we think it will, but it doesn’t erase the guilt.
FDA-Approved Rytelo a ‘Game Changer’ for Some Patients with MDS
Approximately half of the patients with MDS who responded to treatment with Rytelo went a year without needing a blood transfusion, one expert explained.
FDA Approves Rytelo for Some With Low- to Intermediate-1-risk MDS
The Food and Drug Administration has approved Rytelo to treat certain patients with low- to intermediate-1 risk MDS with transfusion-dependent anemia.
Reblozyl Continues to Improve MDS Transfusion Independence
Patients with myelodysplastic syndromes tended to have longer periods of time without needing a red blood cell transfusion when treated with Reblozyl.
Safety Profile of Lower-Dose Oral Onureg Remains Consistent in Lower-Risk MDS
The safety profile of 200 milligrams and 300 milligrams of oral Ongureg were similar in patients with lower- to intermediate-risk MDS.
Cancer and Fatigue Go Together
As a cancer survivor, I’m pleading for more research on cancer related fatigue.
Certain Immunotherapy Drugs Not Recommended for Pregnant Women With Cancer
When possible, immune checkpoint inhibitors should be avoided in pregnant women with cancer due to lung inflammation and possible miscarriage, researchers found.
Social Support Is Key During BiTE Therapy for Blood Cancers
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
Nurse Says CAR-T Cell Therapy is a ‘Mind-Blowing’ Advancement
For patients with blood cancers, CAR-T cell therapy has been a “mind-blowing” advancement for treatment in the cancer space.
Pelabresib Combo Leads to Outcomes Linked to Better Survival in Myelofibrosis
Pelabresib plus Jakafi led to a reduction in spleen size and was tolerable in patients with myelofibrosis, according to data from MANIFEST-2.